| Characterizing clinically significant extravascular hemolysis in adults with PNH on ravulizumab or eculizumab treatment |
|
Blood Advances |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Infections in lower-risk myelodysplastic syndromes - prevalence and risk factors: a report from the European MDS Registry |
|
Haematologica |
Myelodysplastic Syndromes (MDS) |
| Optimal timing of allogeneic hematopoietic stem cell transplant in MDS |
|
Leukemia & Lymphoma |
Myelodysplastic Syndromes (MDS) |
| Excellent Outcomes in Feasibility Study of Radiation-Free Conditioning and Transplant in Pediatric Severe Aplastic Anemia. |
|
Transplantation and Cellular Therapy |
Aplastic Anemia |
| Up-front alternative donor HCT in severe aplastic anemia: gaps and opportunities to translate evidence into practice. |
|
Blood Advances |
Aplastic Anemia |
| Romiplostim for aplastic anemia: beyond an eltrombopag alternative. |
|
Haematologica |
Aplastic Anemia |
| The landscape of disease: mapping aplastic anemia |
|
Blood |
Aplastic Anemia |
| ESCALATing care? Eltrombopag in pediatric aplastic anemia |
|
Blood Advances |
Aplastic Anemia |
| Allogeneic Stem Cell Transplant for Myelofibrosis and Myelodysplastic Syndromes: A Contemporary Review |
|
American Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
| New Approvals in Low- and Intermediate-Risk Myelodysplastic Syndromes |
|
American Society of Clinical Oncology Educational Book |
Myelodysplastic Syndromes (MDS) |
